Stage IV Papillary Thyroid Cancer
specificStage IV includes: IVA (T4a, N0, M0); (T4a, N1a, M0); (T1, N1b, M0); (T2, N1b, M0); (T3, N1b, M0); (T4a, N1b, M0); IVB (T4b, Any N, M0); IVC (Any T, Any N, M1). T4a: Moderately advanced local disease. Tumor of any size extending beyond the thyroid gland capsule to invade subcutaneous soft tissues, larynx, trachea, esophagus, or recurrent laryngeal nerve. T1: Tumor size 2 cm or less in greatest dimension, limited to the thyroid gland. T2: Tumor more than 2 cm but not more than 4 cm in greatest
8
Centers
0
Active Trials
—
Cancer Funding
Top Centers for Stage IV Papillary Thyroid Cancer(8)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive | 56.2 |
| 2 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive | 56.2 |
| 3 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive | 56.2 |
| 4 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive | 56.2 |
| 5 | Case Comprehensive Cancer CenterCleveland, OH NCI Comprehensive | 56.2 |
| 6 | Cleveland Clinic Cancer CenterCleveland, OH | 56.2 |
| 7 | Georgetown Lombardi Comprehensive Cancer CenterWashington, DC NCI Comprehensive | 56.2 |
| 8 | Boston University Cancer CenterBoston, MA | 56.2 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →